Skip to content
BOE-A-2026-6735 ·23 March 2026 ·Resolution Medium impact
Labour

Pharmaceutical companies with employees: 1 January 2025 deadline to apply new collective agreement

The Mediterranean Pharmaceutical Brotherhood Collective Agreement enters into force on 1 January 2025, following publication in the BOE by resolution of the Directorate General of Labour. It remains in effect until 31 December 2028 and is subject to extension. This agreement establishes specific working conditions for the pharmaceutical commercial distribution sector, which must be applied from that date.

In 2 key points

  1. The agreement enters into force on 1 January 2025 (art. 90.2 y 3 del RDL 2/2015)
  2. Valid until 31 December 2028, subject to extension (art. 90.2 y 3 del RDL 2/2015)

How it affects those involved

Pharmaceutical companies in commercial distribution must apply the new agreement's conditions from 1 January 2025. Employees will be subject to new salary and working hour conditions. Labour advisors must update reports and contracts to comply with the new collective framework. Regional authorities must verify compliance with the agreement during inspections.

Lifecycle

2026-03-23PublishedPublished in the BOE
2025-01-01Into forceComes into force (art. 90.2 y 3 del texto refundido aprobado por Real Decreto Legislativo 2/2015, de 23 de octubre)
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The labour team reviews your specific situation.

Talk to the labour team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact